Intelligence · Clinical Development
Pipeline search results
Programs matching “Sutro Biopharma” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 10 pipeline programs matching "Sutro Biopharma" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Luveltamab tazevibulin
SUTRO BIOPHARMA, INC.
Ovarian Cancer
1 trial -
Luveltamab tazevibulin
SUTRO BIOPHARMA, INC.
Acute Myeloid Leukemia (AML)
1 trial -
Luveltamab tazevibulin
SUTRO BIOPHARMA, INC.
Lung Cancer
1 trial -
REFRaME-P1
SUTRO BIOPHARMA, INC.
Acute Myeloid Leukemia (AML)
1 trial -
STRO-002
SUTRO BIOPHARMA, INC.
Neoplasm Malignant
1 trial -
STRO-002-GM3
SUTRO BIOPHARMA, INC.
Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal cancers)
1 trial -
STRO-001
SUTRO BIOPHARMA, INC.
B-cell Lymphoma
1 trial -
STRO-002
SUTRO BIOPHARMA, INC.
Ovarian Cancer
2 trials -
STRO-002-GM2
SUTRO BIOPHARMA, INC.
Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal cancers)
1 trial -
STRO-004
SUTRO BIOPHARMA, INC.
Head and Neck Squamous Cell Carcinoma HNSCC
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.